Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 243 of 1,261

  1. US 11427646

    Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis

    B CELL DESIGN · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  2. US 11427816

    Cancer treatment through RLIP76 partial depletion

    The Board of Regents of the University of Texas System · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  3. US 11426348

    Compositions of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  4. US 11426393

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  5. US 11427581

    JAK inhibitor and use thereof

    ZHUHAI UNITED LABORATORIES CO., LTD. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  6. US 11427605

    Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine

    Takeda Pharmaceutical Company Limited · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  7. US 11427571

    Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

    DENALI THERAPEUTICS INC. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  8. US 11426373

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Jazz Pharmaceuticals Ireland Limited · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  9. US 11427540

    Formulations of T-type calcium channel modulators and methods of use thereof

    PRAXIS PRECISION MEDICINES, INC. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  10. US 11427822

    Modified double-stranded RNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  11. US 11426486

    Chitosan-containing formulations

    PRIMEX EHF · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  12. US 11426418

    Injectable long-acting semi-solid gel formulations

    MIRA PHARMA CORPORATION · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  13. US 11426464

    Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

    The Board of Regents of the University of Texas System · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  14. US 11426385

    Methods of improving cancer chemotherapy

    THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  15. US 11426420

    Inhibitors of short-chain dehydrogenase activity for treating coronary disorders

    The Board of Regents of the University of Texas System · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  16. US 11427823

    Targeted compositions

    ARBUTUS BIOPHARMA CORPORATION · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  17. US 11427644

    Dual antigen-induced bipartite functional complementation

    Julius-Maximilians-Universitat Wurzburg · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  18. US 11427634

    Human anti-semaphorin 4D antibody

    VACCINEX, INC. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  19. US 11426409

    Compounds, compositions and methods for treating or preventing HER-driven drug-resistant cancers

    The Regents of the University of Colorado · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  20. US 11426467

    Dosage regimes for the administration of an anti-CD25 ADC

    ADC THERAPEUTICS SA · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  21. US 11426448

    Methods for treatment of erectile dysfunction with sonic hedgehog compounds

    The Board of Regents of the University of Texas System · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  22. US 11426446

    Stable aqueous formulations of aflibercept

    Coherus BioSciences, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  23. US 11426379

    Combination of local and systemic therapies for enhanced treatment of dermatologic conditions

    Provectus Pharmatech, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  24. US 11426414

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.